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Background: c-erbB2, a proto-oncogene coding epidermal growth factor receptor-like receptor, also as a
chemosensitivity/prognosis marker for gynecologic cancer, may be involved in initiation of growth of rat primordial
follicles. The aim of the present study is to investigate the role and signal pathway of c-erbB2 in onset of rat
primordial follicle development.
Methods: The expression of c-erbB2 mRNA and protein in neonatal ovaries cultured 4 and 8 days with/without
epidermal growth factor (EGF) were examined by in situ hybridization, RT-PCR and western blot. The function of c-
erbB2 in the primordial folliculogenesis was abolished by small interfering RNA transfection. Furthermore, MAPK
inhibitor PD98059 and PKC inhibitor calphostin were used to explore the possible signaling pathway of c-erbB2 in
primordial folliculogenesis.
Results: The results showed that c-erbB2 mRNA was expressed in ooplasm and the expression of c-erbB2
decreased after transfection with c-erbB2 siRNA. Treatment with EGF at 50 ng/ml significantly increased c-erbB2
expression and primary and secondary follicle formation in ovaries. However, this augmenting effect was
remarkably inhibited by c-erbB2 siRNA transfection. Furthermore, folliculogenesis offset was blocked by calphostin
(5 × 10(-4) mmol/L) and PD98059 (5 × 10(-2) mmol/L), but both did not down-regulate c-erbB2 expression. In
contrast, the expressions of p-ERK and p-PKC were decreased obviously by c-erbB2 siRNA transfection.
Conclusions: c-erbB2 initiates rat primordial follicle growth via PKC and MAPK pathways, suggesting an important
role of c-erbB2 in rat primordial follicle initiation and development.
Background
Folliculogenesis is a complex process consisting of
sequential and ordered follicular development and
growth. Although much is known about the events and
regulation of the later stages of ovarian follicular devel-
opment, the early follicular development is very poorly
understood. More recently, attention has focused on
regulation of the initiation of follicular growth (follicle
activation) [1,2]. The initiation of follicular growth and
progression beyond the primary follicle stage requires
locally produced factors and peptides, which can occur
without gonadotrophins [3-6]. The local growth factors
such as epidermal growth factor (EGF), stem cell factor
(SCF), basic fibroblast growth factor (bFGF) and serum
anti-Mullerian have been known to be necessary to
induce primordial follicle development and initiate folli-
culogenesis [7-12].
There is accumulating evidence implicating EGF as a
key regulator of primordial follicle development in
mammals. EGF has been shown, as mitogen for cultured
granulosa cells, to stimulate oocyte growth during the
primordial to primary follicle transition in vitro [8,13],
and EGF receptor has been demonstrated in oocytes
from primordial and primary follicles in many kind of
species [14-16]. Furthermore, EGF triggered primordial
follicle development by stimulating proliferation of gran-
ulosa cells [17]. However, the molecular mechanism by
which EGF triggers primordial follicle development has
not been fully clarified. c-erbB2, a member of the EGF
receptor family, encoding a transmembrane EGF recep-
tor [18,19], is expressed in primordial germ cells, granu-
losa cells, luteal cells and oocytes [20,21]. c-erbB2 is also
* Correspondence: yuehuizheng@163.com
† Contributed equally
Department of Physiology Reproduction, Medical College of Nanchang
University, Nanchang, China
Li-Ping et al. Reproductive Biology and Endocrinology 2010, 8:66
http://www.rbej.com/content/8/1/66
© 2010 Li-Ping et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons
Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in
any medium, provided the original work is properly cited.reported as a marker for chemosensitivity and prognosis
of breast and ovarian cancer [22,23].
Recently, we focused on characterizing the effect of c-
erbB2 on oocyte maturation and found that c-erbB2
induced oocyte maturation via activation of mitogen-
activated protein kinase (MAPK) [24]. MAPKs are
known as extracellular-signal-regulated kinases (ERKs),
and ERK1/2 are known as classical MAP kinases. In the
present study, we tested the expression of c-erbB2
mRNA and protein translation and investigated the role
and signaling pathway of c-erbB2 in primordial follicle
development. In addition, we explore the molecular
mechanism of EGF effect on primordial folliculogenesis.
Methods
Animals and reagents
Animal use was approved by the Committee of Nan-
chang University for Animal Research. Sprague Dawley
rats (obtained from the Animal Care of Medical College
of Nanchang University) were used for all the experi-
ments. EGF, PD98059 (a MAPK inhibitor) and calphos-
tin (a PKC inhibitor) were purchased from Sigma (St.
Louis MO).
Histology and organ culture
Ovaries from 2-day-old rats were collected fresh or cul-
tured for 4 and 8 days, with 20 ovaries in each group.
Fresh ovaries were fixed in Bouins solution for 1-2 h,
embedded in paraffin, sectioned (3-5 × 10
-3 mm), and
were stained with hematoxylin and eosin. The number
of follicles at each developmental stage was counted in
two serial sections from the largest cross-section
through the center of the ovary [25]. Normally, two
ovaries were in each treatment group as a replicate and
150-200 follicles were present in an ovary cross-section.
Experiments were repeated three times (therefore, n = 6
for each treatment group). Follicles were classified as
either primordial (stage 0), or as one of the developing
preantral stages (stage 1-4) as described previously [25].
Briefly, primordial follicles consist of one oocyte par-
tially or completely encapsulated by flattened squamous
pregranulosa cells. Developing (stage 1-4) follicles con-
tain successively more cuboidal granulosa cells in layers
around the oocyte. Whole ovaries were cultured on
sponge in 0.5 ml of Waymouth MB 752/1 medium sup-
plemented with 0.1% BSA (Sigma, St. Louis, MO), 0.1%
albumax (Gibco BRL, Gaithersburg, MD). Ovaries were
cultured at 37°C with 5% CO2 in 4-well plates (Nunc
plate; Applied Scientific, South San Francisco, CA),
ovaries were randomly assigned to treatment groups
with 1-3 ovaries per well. The medium was changed
every 2 days. During organ culture, ovaries were treated
with EGF (50 ng/ml) and c-erbB2 small interfering RNA
(siRNA, 0.1 mmol/L) alone or in combinations. In
addition, ovaries were challenged with PD98059 (5 ×
10
-2 mmol/L) or calphostin (5 × 10
-4 mmol/L).
In situ hybridization
Localization of c-erbB2 mRNA was determined by in
situ hybridization. The c-erbB2 multiphase oligonucleo-
tide probes digoxigenin-labeled were as follows: 1)5’-G
G A A GGACGTCTTCCGCAAGAATAACCAACTGG
CT-3’;2)5’- GCTTTGTACACA C T G T A C C T T G
GGACCAGCTCTTC-3’;3)5’- CGGACCTCTCC
T A C A T G C CCATCTGGAAGTACCCG3’.Before
hybridization, the liquids and containers have been
strictly treated with 0.1% DEPC. Slides were deparaffi-
nized and rehydrated with 3% H2O2, and subjected to
enzymatic digestion with pepsin for 2-3 min(diluted
with 3% citric acid, fresh), and then incubated in pre-
hybridization solution at 37°C for 2 h. After discarding
the prehybridization solution, the slides were transferred
to hybridization solution overnight with water, covering
the specimens on special coverslips of the situ hybridiza-
tion. The next morning the coverslips were opened and
washed three times in 2 × SSC (standard saline Citrate,
containing Nacl 3 mol/L, sodium citrate 0.3 mol/L),
0.5 × SSC, 0.2 × SSC, and then were incubated with the
incubating solution at 37°C for 30 min. Slides were
exposed to biotinylated mouse anti-digoxigenin IgG for
60 min. Finally, the immunoreactions were detected by
using SABC (Strept-Avidin-Biotin Complex) system.
Slides were counterstained with haematoxylin before
observation. As negative control we used pre-hybridiza-
tion solution which without probe to replace hybridiza-
tion solution with probe solution.
Quantitative reverse transcriptase-polymerase chain
reaction (RT-PCR)
Expression of mRNA for c-erbB2 was assayed by RT-
PCR. Ovaries from the same culture well were pooled
to make single RNA sample. RNA was extracted using
the Trizol reagent (Sigma, St. Louis, MO). Total RNA
from each sample was reverse transcribed into cDNA
using a standard oligo-dT RT protocol. cDNA samples
were used as template for polymerase chain reaction
(PCR) analysis. The 2 × EasyTaq PCR Supermix kit
(TRansGen Biotec) was used according to the manu-
facturer’si n s t r u c t i o n s .T h ec-erbB2 primers forward:
5’-CAGTGTGTCAACTGCAGTCA-3’, reverse: 5’-
CAGGAGTGGGTGCAGTTGAT-3’. The house-
keeping reference gene GAPDH primers forward:
5’-GCAAGTT CAACGGCACAG-3’, reverse:5’-
AGGTGG AAG AATG GGAGTTGCT- 3’. The proto-
col was 94°C for 4 min, then 35 cycles of 95°C for 15
sec, 55°C for 60 sec and 72°C for 2 min. Fluorescent
detection data were analyzed and normalized for
c-erbB2 mRNA levels to GAPDH mRNA levels. The
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direct sequencing (Shanghai Sangon Biological Engi-
neering Technology & Services Co., Ltd)
Western blotting analysis
Tissue protein extracts were electrophoretically sepa-
rated under reduced conditions using NuPAGE 4-12%
Bis-Tris gels (Invitrogen; Paisley, UK). Standard Mark
(Invitrogen) was used as the molecular weight stan-
dard. Proteins were then electrotransferred to nitro-
cellulose membranes (BIORAD; Munich, Germany)
and the immunoblots were subsequently blocked for
2 h at room temperature in TBST (TBS containing
0.1% Tween 20) containing 5% nonfat dry milk. The
membranes were incubated overnight at 4°C with
antibodies against PCNA, ErbB2, p-ERK1/2, p-PKC or
b-actin (Sigma). The b-actin bands were used as an
internal control for equal loading. After rinsing with
TBST, the membranes were incubated for 30 min at
room temperature with horseradish peroxidase-conju-
gated anti-rabbit or anti-mouse secondary antibodies
(Amersham; Aylesbury, UK). Finally, the membranes
were stained with DAB according to the manufac-
turer’s instructions and analyzed with Gel image ana-
lysis system.
Designing and transfecting of c-erbB2 siRNA
EASY siRNA kit was purchased from Shanghai Chemi-
cal Technology Co., Ltd. target to c-erbB2 gene
(NM_017003). The c-erbB2 siRNA was as follows:
sense, 5’-CAGUACCUUCUACCGUUCAtt-3’,a n t i -
sence, 5’-UGAACGGUAGAAGGUA CUGtt-3’.T r a n s -
fection was followed on the manufacturer’s
instructions. Briefly, 3 × 10
-3 ml 2 × 10
-2 mM
of siRNA and 2 × 10
-3 ml of liposomes (METAFEC-
TENE) were each added to in 5 × 10
-2 ml free of
serum and antibiotics medium respectively, and the
two solutions were combined without any mixture pro-
cedures and incubated at room temperature for 15-20
min. After incubation, siRNA-lipid complexes were
added to culture flasks (containing 0.5 ml medium and
ovaries) and swirl flasks and incubated at 37°C in CO2
incubator. The final siRNA concentration of transfec-
tion was 0.1 mmol/L. Ovaries were cultured with/with-
out 0.1 mmol/L targeting siRNA for 12 h. The
medium was replaced after 12 h transfection with fresh
medium containing no siRNA, and ovaries were cul-
tured for 24 h and then collected to detect gene
expression and protein translation by using RT-PCR
and western-blot. Ovaries without transfection were
used as the control. The negative control was the
group transfected with negative siRNA. In addition,
ovaries were processed for morphometric assessment
of the development of primordial follicles.
Statistics
The experiment was repeated three times. All data were
presented as the means ± SEM and analyzed by
ANOVA and Duncan’s new multiple range tests. p <
0.05 was considered significantly difference.
Results
Expression of c-erbB2 in the ovaries during the initiation
of growth of primordial follicle
To examine the expression of c-erbB2, in situ hybridiza-
tion and RT-PCR were performed. Hybridization histo-
chemistry demonstrated that c-erbB2 mRNA was
expressed in ooplasm from primordial follicles of 2 day
postnatal ovaries to cultured 8 days of ovaries. More-
over, c-erbB2 mRNA expression increased with pro-
longed culture, especially in proliferating cumulus cells
of cultured ovaries. To investigate more direct actions of
EGF, ovaries were incubated in the absence or presence
of EGF before RNA collection and analysis. After treat-
ment with EGF (50 ng/ml), the ovaries showed more
intense labeling for c-erbB2 mRNA than the control
(Fig. 1).
After RT-PCR, cDNA was amplified from RNA
extracted from cultured ovaries to assess c-erbB2 expres-
sion in response to different treatments (Fig. 2). As pre-
viously discussed, the neonatal ovary is primarily
composed of early-stage primordial follicles, which can
initiate growth when cultured in vitro. As shown in Fig.
2, c-erbB2 mRNA appeared more abundant with primor-
dial follicles that had initiated growth and EGF treat-
ment increased c-erbB2 mRNA expression compared to
controls (P < 0.05), and the results were consistent with
in situ hybridization analysis.
Western blotting detection of PCNA protein in the ovaries
To identify the growth of primordial follicle, the expres-
sion of proliferating cell nuclear antigen (PCNA) protein
was detected by western blotting analysis. PCNA was
expressed in the rat ovary, with a positive band in most
of the samples. Differences in the intensity of the band
from different group of ovaries were observed, depend-
ing on the cultured days. Our data indicated that PCNA
protein levels increased with the cultured days, and EGF
further enhanced PCNA protein levels by promoting
primordial follicle development (Fig. 3).
Effect of c-erbB2 siRNA on primordial follicle development
To clarify whether c-erbB2 pathway was involved in
initiation of growth of primordial follicle, we synthesized
in vitro three siRNAs targeting the c-erbB2 mRNA and
transferred them into the newborn rats’ ovary to exam-
ine the effect of c-erbB2 on primordial follicle develop-
ment. The siRNA with maximal effect was used in the
present study (data not shown). The specificity of the
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Page 3 of 9Figure 1 In situ hybridization detection of c-erbB2 mRNA in the ovaries. (A), Control (ovary of 2-day-old rat); (B), Ovary of 2-day-old rat
cultured for 4 days; (C), Ovary of 2-day-old rat cultured for 8 days; (D), Ovary of 2-day-old rat cultured for 4 days with 50 ng/ml EGF; (E), Ovary
of 2-day-old rat cultured for 8 days with 50 ng/ml EGF; (F), Negative control. Scale bar: 2.5 × 10
-2 mm.
Figure 2 RT-PCR detection of c-erbB2 mRNA in the ovaries. (A),
The expressions of c-erbB2 mRNA (322 bp) by RT-PCR; (B),
Semiquantitative analysis of the RT-PCR result; (1), Control (ovary of
2-day-old rat); (2), Ovary of 2-day-old rat cultured for 4 days; (3),
Ovary of 2-day-old rat cultured for 8 days; (4), Ovary of 2-day-old rat
cultured for 4 days with 50 ng/ml EGF; (5), Ovary of 2-day-old rat
cultured for 8 days with 50 ng/ml EGF. Data are presented as
means ± SEM (n = 3). *, P < 0.05; **, P < 0.01 vs control group; Δ,
P < 0.05 vs group 3.
Figure 3 Western blotting detection of PCNA protein in the
ovaries. (A), The expressions of. PCNA protein by western blot; (B),
Semiquantitative analysis of the western-blot result. (1), Control
(ovary of 2-day-old rat); (2), Ovary of 2-day-old rat cultured for 4
days; (3), Ovary of 2-day-old rat cultured for 8 days; (4), Ovary of 2-
day-old rat cultured for 4 days with 50 ng/ml EGF; (5), Ovary of 2-
day-old rat cultured for 8 days with 50 ng/ml EGF. Data are
presented as means ± SEM (n = 3). **, P < 0.01 vs control group; Δ,
P < 0.05 vs group 3.
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levels of c-erbB2 mRNA in ovaries exposed to c-erbB2
siRNA. Although nontargeting control siRNA did not
affect the basal transcript level of the gene, c-erbB2
siRNA specifically and appreciably knocked down the
levels of c-erbB2 mRNA in ovaries cultured for 4 days.
Meanwhile, ErbB2 protein expression was also reduced
(Fig. 4 and 5).
A primordial follicle is composed of an oocyte sur-
rounded by flattened pregranulosa cells, and can initiate
the growth spontaneously when cultured in vitro. Statisti-
cal analysis revealed that, compared with the control
(cultured for 8 days without treatment), siRNA treatment
significantly inhibited the growth of primordial follicle
and reduced the percentage of secondary follicles. The
highest percentage of secondary follicles was observed
after 8 day culture with 50 ng/ml EGF. However, EGF-
stimulated increase of secondary follicles was obviously
inhibited by concurrent treatment with c-erbB2 siRNA
(Fig. 6). These data indicate that c-erbB2 siRNA can
block spontaneous and EGF-induced activation of pri-
mordial follicles by suppressing the expression of c-erbB2.
Expressions of ErbB2, p-ERK and p-PKC protein after
c-erbB2 siRNA transfection
To investigate the signal pathway of c-erbB2, siRNA was
transfected into the cultured neonatal rat ovaries in
vitro by liposome. After 8 day culture, western blot ana-
lysis was performed to measure the expressions of
ErbB2, p-ERK and p-PKC protein after c-erbB2 siRNA
transfection. As shown in Fig. 7, the expression of
ErbB2, p-ERK and p-PKC protein were remarkably
inhibited by c-erbB2 siRNA, compared with the control.
Figure 4 Effect of c-erbB2 siRNA on c-erbB2 mRNA expression.
(A), Expression of c-erbB2 mRNA (322 bp) measured by RT-PCR in
cultured ovaries after c-erbB2 siRNA transfection. (B),
Semiquantitative analysis of the RT-PCR results. Control is the group
without transfection; Negetive control is the group transfected with
negative control siRNA. Data are presented as means ± SEM (n = 3).
**, P < 0.01.
Figure 5 Effect of c-erbB2 siRNA on ErbB2 protein expression.
(A), Expression of c-erbB2 protein in cultured ovaries after siRNA
transfection by Western blot. (B), Semiquantitative analysis of the
western-blot result. Control is the group without transfection;
Negetive control is the group transfected with negative control





















































A Control siRNA EGF EGF+siRNA
Figure 6 Effect of c-erbB2 siRNA on the initiation of primordial
follicle growth. (A), Ovaries were cultured for 8 days with
treatments: A, control; B, 0.1 mmol/L siRNA targeted c-erbB2;C ,5 0
ng/ml EGF; D, 0.1 mmol/L siRNA+50 ng/ml EGF. (B), The number of
follicles was counted in serial cross-sections. Percentage of the
number of each category over the total number was plotted. Data
are presented as means ± SEM (n = 5). Bars with different
superscripts are statistically different (P < 0.01).
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development
The expression of c-erbB2 mRNA were examined by
RT-PCR. The results showed that PD98059 and calphos-
tin did not significantly affect the expression of c-erbB2
mRNA (Fig. 8). Compared with the control, c-erbB2
siRNA, PD98059 and calphostin significantly inhibited
the primordial to primary follicle transition of primor-
dial follicles after 8 days culture. The number of primor-
dial follicles was markedly increased and the number of
primary follicles and secondary follicles was obviously
decreased (Fig. 9). These data suggest that MAPK and
PKC pathways are involved in initiation of growth of rat
primordial follicles.
Discussion
Follicles form when some of primordial germ cells are
enveloped by a single layer of flattened pre-granulosa
cells (pre-GC). When some follicles leave the resting
pool and start the initiation of follicular growth (folli-
cle activation), the granulosa cells (GC) become cuboi-
dal and begin to express markers of cell proliferation,
such as PCNA. EGF is essential to initiate growth of
primordial follicles [17,26]. Our previous results
Figure 7 Effect of c-erbB2 siRNA on the expressions of ErbB2,
p-ERK and p-PKC protein. (A), The expressions of ErbB2, p-ERK and
p-PKC protein in the ovaries by western blot; (B), Semiquantitative
analysis of the western-blot result. Control is the group without
transfection; Negetive control is the group transfected with negative
control siRNA. Data are presented as means ± SEM (n = 3). **, P <
0.01 vs control group; ΔΔs, P < 0.01 vs negative control.
Figure 8 Effect of MAPK inhibitor PD98059 and PKC inhibitor
calphostin on the expression of c-erbB2 mRNA. (A), The
expression of c-erbB2 mRNA (322 bp) in the ovaries by RT-PCR; (B),
Semiquantitative analysis of the RT-PCR results. Data are presented











































Control siRNA PD98059 Calphostin
Figure 9 Effect of c-erbB2 siRNA, PD98059 and calphostin on
the initiation of primordial follicle growth. (A), Ovaries were
cultured for 8 days with treatments: A, control; B, 0.1 mmol/L siRNA;
C, 5 × 10
-2 mmol/L PD98059; D, 5 × 10
-4 mmol/L calphostin. (B),
The number of follicles was counted in serial cross-sections.
Percentage of the number of each category over the total number
was plotted. Data are presented as means ± SEM (n = 5) **, P <
0.01 vs control.
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regulation of functions of granulosa cells and matura-
tion of oocytes [24,27]. Interestingly, c-erbB2 also med-
iates spermatogonial proliferation in newt testis [28].
Therefore, we hypothesized that EGF might stimulate
the initiation of primordial follicles growth via the
c-erbB2 pathway.
In the present study, we examined the expression of
c-erbB2 during primordial folliculogenesis and investi-
gated the influence of EGF on c-erbB2 expression as
well as the effects of c-erbB2 down-regulation on the
initiation of primordial follicle growth and on the acti-
vating role of EGF. ErbB2 protein plays the role of epi-
dermal growth factor receptor (EGFR) and hasn’ta
specific ligand. ErbB receptor has distinct signaling
properties depending on its dimerization. ErbB2,t h e
preferred heterodimerization partner of all ErbB recep-
tors, is a mediator of lateral signaling [29]. We investi-
gated the relation between c-erbB2 and MAPK or PKC
signaling pathways during primordial folliculogenesis.
Our study revealed that expression of c-erbB2 mRNA
was present in oocytes of primordial follicles, and also
appeared in cuboidal granulosa cells after initiation of
follicular growth. The expression of c-erbB2 mRNA
increased in proliferated multilayer granulosa cells after
prolonged culture. EGF promoted PCNA protein
expression and follicular growth by initiating primordial
follicle development. In addition, EGF promoted the
expression of c-erbB2 mRNA. Therefore, we conjecture
that EGF and c-erbB2 might be involved in the onset of
primordial follicle development.
To further understand the action of c-erbB2 during
primordial folliculogenesis, we used the synthetic siRNA
for c-erbB2 to transfect ovarian cells in organ culture.
We observed the condition of the growth initiation of
primordial follicles through inducing c-erbB2 gene silen-
cing. In the current experiment, most of the primordial
follicles in the control group developed to the primary
follicles, whereas the number of primary follicles and
secondary follicles was significantly decreased by c-erbB2
siRNA. Furthermore, c-erbB2 siRNA blocked the pro-
moting effect of EGF on the initiation of primordial fol-
licle growth. ErbB2, an orphan receptor tyrosine kinase,
which can dimerize with other ligand-activated members
of the EGF receptor family, might be a selecting marker
for initiation of follicular growth. We observed that
c-erbB2 siRNA inhibited the expression of ErbB2 protein.
These results suggest that c-erbB2 plays an important
role on the initiation of primordial follicle growth and
mediates the regulating role of EGF as a key signal
molecule.
A variety of signaling pathways, including the MAPK
and PKC regulating systems, are involved in the initia-
tion of the growth of primordial follicles [30,31].
Phosphorylated MAPK (active) exists in some proliferat-
ing granulosa cells, and the activity of MAPK constantly
increases during he process of oogonium proliferation
[32]. The PKC family has been implicated in various
functional responses on the regulation of cell develop-
ment including cell growth, cell cycle progression, cell
survival, apoptosis and cell differentiation. As a potent
and selective inhibitor of MAP kinase kinase (MEK),
PD-98059 blocks activation of MEK binding to the ATP
site of dephosphorylation MEK, thereby inhibites phos-
phorylation and activation of MAP kinase1, 2 (ERK1/2)
[33]. Calphostin C, a potent inhibitor of protein kinase
C, inhibits phorbol dibutyrate binding to PKC [34]. In
this study, both PD98059 and calphostin significantly
inhibited the development of primordial follicles, sug-
gesting that MAPK and PKC signal pathways are
involved in the initiation of primordial follicle growth.
However, the upstream and downstream relationship
between MAPK or PKC and c-erbB2 is still unclear dur-
ing primordial folliculogenesis. Therefore, we investi-
gated the MAPK and PKC pathways as possible
mediators for the expression of c-erbB2 using calphostin
and PD98059. Both inhibitors did not change the
expression of c-erbB2 mRNA, while the expression levels
of PKC and MAPK protein were significantly decreased
by c-erbB2 siRNA transfection in primordial follicles.
These results indicated that c-erbB2 might be an
upstream activator of MAPK and PKC, which regulated
the initiation of primordial follicle growth at least in
part via the activation of MAPK and PKC signal path-
ways (Fig.10).
A complex signal network system composed of a vari-
ety of autocrine, paracrine and endocrine factors regu-
lates the growth of primordial follicles via intercellular
communications, and it has been demonstrated that the
growth of primordial follicles was associated with pre-
cise spatiotemporal expression of multiple genes and
Figure 10 EGF signal transduction figure.
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The signaling pathways, such as PI3K and mTORC1
pathways, regulate the activation of primordial follicles
and the early development of ovarian follicles [37,38].
However, the exact mechanism by which the various
factors regulate the growth of primordial follicles has
not yet been fully understood. c-erbB2 might have roles
in the growth of primordial follicles beyond that of
mediating EGF signaling. It also might regulate prolif-
eration of granulosa cells and cumulus cells, which have
close signaling communication with oocytes, to govern
initiation of follicular growth, development, and steroi-
dogenesis. Futher research of c-erbB2 functions may pro-
vide novel information for understanding the
mechanism of the follicular initiation and development.
Conclusions
In conclusion, we showed that EGF promoted the initia-
tion of primordial follicle development and the expres-
sion of c-erbB2 in ovaries, whereas the promoting effect
of EGF was blocked by c-erbB2 siRNA transfection. In
addition, the initiation of primordial follicle growth was
inhibited by MAPK or PKC inhibition. The expression
of ErbB2, p-ERK and p-PKC protein and primordial fol-
licle development were inhibited by c-erbB2 siRNA
transfection. These results indicated that c-erbB2 played
an important role in primordial follicle initiation and
development and the effect of c-erbB2 might be
mediated by a mechanism involving the PKC and
MAPK pathways.
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